Similar documents
8/24/18. Dementia. Risk of Dementia Following Traumatic Brain Injury: A Review of the Literature. Media Presence. Media Presence

Plan for Today. Brain Injury: 8/4/2017. Effective Services for People Living with Brain Injury. What is it & what causes it?

DVHIP. TBI: Clinical Issues, Controversies, and Learning from Patients. Defense and Veterans Head Injury Program. What is Neuropsychology?

The Dangers of CTE. James Ryan Cox. Skylar Spriggs. Sawyer Solfest. Team THS131

Treatments = 0 10/19/2018. Concussion is not a diagnosis!!! Multiple Clinical Trials for Traumatic Brain Injury (TBI) Treatment

G. Alexander Hishaw, MD Assistant Professor of Neurology & Psychiatry University of Arizona Health Sciences Center Staff Neuropsychiatrist of

Health and Aging after TBI: Current research and future directions

Mild Cognitive Impairment (MCI)

Blood Biomarkers for Brain Injury. Dianne Langford Associate Professor Department of Neuroscience Lewis Katz School of Medicine at Temple University

Neuro degenerative PET image from FDG, amyloid to Tau

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Outline of Lecture 2/13/2018

the injured brain, the injured mind.

Biomarkers for Alzheimer s disease

Conflicts. Objectives. You can t hide. Epidemiology 4/16/2018. I have no relevant financial relationships to disclose.

The role of the vascular system in dementia

Concussion Update and Case Presentations

Peer Reviewed Alzheimer s Research Program

TRAUMATIC BRAIN INJURY: CHRONIC TRAUMATIC ENCEPHALOPATHY

Outcomes for Critically Ill Sepsis Survivors

Conceptualization of Functional Outcomes Following TBI. Ryan Stork, MD

Concussion: Not Just For Athletes

Chronic Effects of Neurotrauma Consortium (CENC)

Dhiren J. Naidu MD FRCPC Dip. Sport Med.

Ageing after TBI: Survival & Health Issues. Is TBI a Chronic Condition?

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

UNIVERSITY OF WESTERN ONTARIO

Epilepsy in dementia. Case 1. Dr. Yotin Chinvarun M..D. Ph.D. 5/25/16. CEP, PMK hospital

Theme Topics Subtopics. Basic and Translational Science. Development of New Models and Analysis Methods

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities


Dementia and Healthy Ageing : is the pathology any different?

New life Collage of nursing Karachi

A Dynamic Model of Care for Late Onset Cognitive Impairment. Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong

E x p E rt W i t n E s s J o u r n a l W i n t E r

Chronic Traumatic Encephalopathy Provider and Parent Essentials

Infiltrative Brain Mass Due To Progressive Alzheimer's Disease

Peer Reviewed Alzheimer s Research Program

Be a part of the solution.

The importance of cognitive ageing for understanding dementia

TREATING NEUROINFLAMMATION, TREATING DISEASE

Understanding Symptoms, Causes, and Risks for Alzheimer s Disease

Concussion in Adventure Athletes Epidemiology and Current Guidelines. Aaron Provance, MD Medical Director

A new approach to Common Sporadic Alzheimer s, Post-Traumatic Alzheimer s, and CTE:

TITLE: Endophenotypes of Dementia Associated with Traumatic Brain Injury in Retired Military Personnel

USE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013

Alzheimer s disease: the state of play

What s New in Dementia?

PET Scanning of Brain Tau in Retired National Football League Players: Preliminary Findings

Type 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

PT/MR evaluation of athletes with postconcussion syndrome

Diabetes Mellitus and Dementia. Andrea Shelton & Adena Zadourian

METABOLIC SYNDROME, NEUROINFLAMMATION AND COGNITIVE IMPAIRMENT: STATE OF LEVEL OUTPATIENT CLINIC IN ITALY

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Fact Sheet Alzheimer s disease

The Primary Care Guide To Understanding The Role Of Diabetes As A Risk Factor For Cognitive Loss Or Dementia In Adults

Translational Neuroscience

TITLE: Optimal Oxygen Saturation Range for Adults Suffering from Traumatic Brain Injury: A Review of Patient Benefit, Harms, and Guidelines

A Critical Review of Chronic Traumatic Encephalopathy

This is the author s final accepted version.

CSF Aβ1-42 predicts cognitive impairment in de novo PD patients

Delirium & Dementia. Nicholas J. Silvestri, MD

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Neuroinflammation in preclinical AD: in vivo evidence

Depression: An Important Risk Factor for Cognitive Decline

Brain Fitness for Positive Aging

Concussion Management

Imaging of Alzheimer s Disease: State of the Art

Emerging CSF and serum biomarkers in atypical dementia. Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018

Complications of Proton Pump Inhibitor Therapy. Gastroenterology 2017; 153:35-48 발표자 ; F1 김선화

THE CANADA-ISRAEL TRANS-ATLANTIC COLLABORATION FOR BRAIN STUDIES

MULTIPLE CONCUSSIONS LEAD TO CHRONIC TRAUMATIC ENCEPHALOPATHY (CTE)

Dietary Supplements, Caffeine, and Cognitive Aging

Alzheimer s Disease without Dementia

Cerebral Blood Flow, Metabolism, and Head Trauma

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

The Practitioner Scholar: Journal of Counseling and Professional Psychology 43 Volume 2, 2013

Sport Concussion Updates:

The Carroll A. Campbell, Jr. Neuropathology Laboratory: A Tool for Dementia Discovery in South Carolina

Dementia Past, Present and Future

TGF-ß1 pathway as a new pharmacological target for neuroprotection in AD. Filippo Caraci

Posttraumatic Stress Disorder and Suicidal Behavior: Current Understanding and Future Directions

Mild Traumatic Brain Injury in Sports, Daily Life, and Military Service

Neuropsychiatric symptoms as predictors of MCI and dementia: Epidemiologic evidence

The significance of traumatic haematoma in the

The ABCs of Dementia Diagnosis

Interventions on Lifestyle and Social Support Factors: Sleep Quality and Disorders

Chronic traumatic encephalopathy: clinical biomarker correlations and current concepts in pathogenesis

8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research

Top Peer Reviewed Journals Neuroscience & Behavior

Learning Objectives. Sports Concussion. Learning Objectives (Cont.) Definitions. Marc Norman, Ph.D. & Amanda Gooding, Ph.D. Department of Psychiatry

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Richard C. Stabb, D.O. Memorial Symposium. Concussion: A Gray Matter, Understanding Concussion

Interested parties (organisations or individuals) that commented on the draft document as released for consultation.

Final Scientific Progress Report

The Calpain / Calpastatin System in TBI and Chronic Neurodegeneration

Transcription:

Johnson, V. E., and Stewart, W. (2015) Traumatic brain injury: Age at injury influences dementia risk after TBI. Nature Reviews Neurology, 11(3), pp. 128-130. (doi:10.1038/nrneurol.2014.241) There may be differences between this version and the published version. You are advised to consult the publisher s version if you wish to cite from it. http://eprints.gla.ac.uk/122377/ Deposited on: 07 September 2016 Enlighten Research publications by members of the University of Glasgow http://eprints.gla.ac.uk

Traumatic brain injury Age at injury influences dementia risk after traumatic brain injury Victoria E. Johnson and William Stewart Traumatic brain injury (TBI) is increasingly recognized as a risk factor for dementia. New data provide further support for this association, and demonstrate the influence of age at injury and injury severity on dementia risk post-tbi; revealing that even mild TBI increases dementia risk in those aged e65 years. Johnson, V. E. and Stewart, W. Nat. Rev. Neurol. advance online publication XX Month 2015; doi:10.1038/ The association between traumatic brain injury (TBI) and increased risk of dementia has garnered intense public and media interest in the past few years. In a newly published, comprehensive study of 164,611 patients with trauma aged e55 years at the time of injury, the strength of this association is explored further 1 ; the results highlighting the influence of age on dementia risk following a TBI. In support of previous work, Gardner and colleagues 1 report an increased dementia risk following a single moderate to severe TBI across their patient cohort at up to 7 years of follow-up. Furthermore, an intriguing aspect of the analysis indicates that even a single, mild TBI might confer increased dementia risk in older patients; defined as those aged e65 at the time of injury. Thus, the implications of this study are that risk of neurodegeneration after TBI is influenced not just by the severity of the initial injury, but also by the patient s age at the time of injury. Page 1 of 7

In the past 5 years considerable attention has been paid to the link between repetitive, mild TBI and neurodegenerative disease. This interest has, in large part, been driven by increasing reports of chronic traumatic encephalopathy (CTE) in autopsy studies of former athletes or military personnel. 2,3 However, the association between exposure to a single moderate or severe TBI and increased risk of dementia has been recognized for some time. Characterization of autopsy acquired material from long-term survivors of a single TBI reveals a complex neuropathology in a proportion of patients. This complex neuropathology, best described as a polypathology, includes abnormal tau and amyloid-² protein accumulation, 4 degeneration, 5 neuroinflammation, white matter degradation and axonal adding further to our appreciation of the full range of CTE pathology. However, although the neurodegenerative pathology of TBI is increasingly understood, conflicting reports exist regarding the epidemiological association of a single TBI with altered risk of dementia, which might reflect methodological limitations of studies on both sides of this debate. 6 Several previous clinical studies have used a methodology comparing incidence of dementia in patients with TBI to that of the general population. In the new study by Gardner et al. 1 a more relevant index population of over 112,000 patients exposed to trauma without TBI provides the control population. Over a follow-up period of up to 7 years after the original injury dementia risk in a cohort of almost 52,000 patients with TBI was assessed in comparison to this cohort of Page 2 of 7

patients exposed to trauma without TBI. As such, the authors attempted to mitigate against potentially unknown behavioural or clinical confounders that might also confer an increased risk of dementia in patients exposed to trauma. Rather than relying on self or informant reporting of dementia, only confirmed, hospital-based diagnoses (International Classification of Diseases, Ninth Revision coded) were used to determine dementia outcome at follow-up. Importantly, patients in which a diagnosis of dementia was made within 1 year following injury were excluded from the analysis. This criterion reduced the possibility that pre-existing dementia acting as a risk factor for trauma, or evolving subacute TBI pathology might confound dementia diagnosis. Using this methodology, and adjusting for all covariables, the data are reported to show an increased dementia risk in patients surviving TBI compared with patients with trauma, without TBI across all age groups studied. Intriguingly, this study also reveals a potential association between age at injury, injury severity and subsequent risk of dementia. The data demonstrate increased dementia risk following either a moderate, or severe TBI across the cohort. However, in the older patients in this study, defined as those aged e65 at time of injury, just a single, mild TBI was sufficient to increase dementia risk. Notably, TBI is a major public health problem in older individuals, with the highest rates of hospitalization from TBI observed in those aged e65. 7 Page 3 of 7

Research has resulted in an increased appreciation of the range of neuropathologies associated with normal ageing, which show overlap with pathologies typically associated with neurodegenerative diseases, including brain atrophy, neurofibrillary tangles and amyloid-β plaques. 8 To avoid the confounding influence of normal ageing, many studies investigating TBI-associated neurodegenerative pathologies often exclude older individuals and focus on younger patients. However, the study by Gardner et al. 1 underlines the pressing need to further examine the interplay between TBI, age and dementia risk. The presence of comorbidities, and their potential contribution to pathophysiology is of particular relevance in this older age group. In this respect, the population of patients with TBI in this study was slightly older, had a higher percentage of males and a higher incidence of cardiovascular comorbidities than the counterpart cohort of patients with trauma without TBI. While the association with dementia risk remained after adjustment for these covariates, the need for robust accounting for comorbidities is critical to further investigation of the potential mechanisms of disease, particularly in mild TBI. Owing to the inherent restrictions of retrospective analyses, one limitation of this work is the inability to exclude previous TBIs that might have occurred prior to the period of study, including repetitive mild exposures. To date, the association between repetitive mild TBI and chronic neurodegeneration has not been robustly explored at a population level, with the vast majority of data being derived from relatively small and highly-selective case series. 2,3 As such, any Page 4 of 7

speculation as to how this potential variable might influence dementia risk is limited. However, Gardner et al. 1 did note that patients with a second TBI during follow-up had twice the dementia risk, suggesting a dose-response relationship. Overall, this work represents an important contribution to our understanding of the association between TBI and increased risk of dementia. These findings also underscore the pressing need for further, well-constructed, longitudinal studies examining the chronic and progressive consequences of TBI across all age groups. Risk of a worse outcome in the acute period following TBI is known to increase with older age. 9,10 Given the advancing average age observed in many national populations, further understanding of any age-associated vulnerability to progressive neurodegenerative outcomes following TBI will be of critical importance. Department of Neuropathology, Laboratory Medicine Building, Southern General Hospital, 1345 Govan Road, Glasgow G51 4TF, UK (W.S.) Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, United States. vje@mail.med.upenn.edu (VEJ) Correspondence to: W.S. william.stewart@glasgow.ac.uk Competing interests: The authors declare no competing interests. 1. Gardner, R. C., et al. Dementia risk after traumatic brain injury vs nonbrain trauma: the role of age and severity. JAMA Neurol. http://dx.doi.org/10.1001/jamaneurol.2014.2668. 2. McKee, A. C., et al. The spectrum of disease in chronic traumatic encephalopathy. Brain 136, 43 64 (2013). 3. Smith, D. H., Johnson, V. E. & Stewart, W. Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat. Rev. Neurol. 9, 211 221 (2013). Page 5 of 7

4. Johnson, V. E., Stewart, W. & Smith, D. H. Widespread tau and amyloidbeta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 22, 142 149 (2012). 5. Johnson, V. E., et al. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 136, 28 42 (2013). 6. Fleminger, S., et al. Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J. Neurol. Neurosurg. Psychiatry 74, 857 862 (2003). 7. Faul, M., Xu, L., Wald, M. M. & Coronado, V. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002 2006. Centers for Disease Control and Prevention [online] http://www.cdc.gov/traumaticbraininjury/pdf/blue_book.pdf. (2010) 8. Savva, G. M., et al. Age, neuropathology, and dementia. N. Engl. J. Med. 360, 2302 2309 (2009). 9. Susman, M., et al. Traumatic brain injury in the elderly: increased mortality and worse functional outcome at discharge despite lower injury severity. J. Trauma 53, 219 223 (2002). 10. Hukkelhoven, C. W., et al. Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J. Neurosurgery 99, 666 673 (2003). Page 6 of 7

Figure 1: Influence of age, and injury severity on neurodegeneration following TBI. The neurodegenerative pathologies described in TBI survivors might also arise through normal ageing (black line). The data presented by Gardner et al. 1 support the hypothesis of an accelerated accumulation of neurodegenerative pathology following a single moderate or severe TBI (red line), so crossing a threshold to clinical symptoms (dotted line) at an earlier age. In contrast, increased dementia risk after mild TBI was only present in patients aged e65 (orange line), implying no meaningful acceleration in neurodegenerative pathologies in patients aged <65 (blue line). Abbreviation: TBI, traumatic brain injury. Modified with permission obtained from Nature Publishing Group Smith, R. M. et al. Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat. Rev. Neurol. 9, 211 221 (2013). even a single, mild TBI might confer increased dementia risk in older patients Gardner and colleagues 1 report an increased dementia risk following a single moderate to severe TBI Victoria E. Johnson Dr Victoria E. Johnson received both her medical degree and Ph.D. from the University of Glasgow, UK. After completing postdoctoral training at the University of Pennsylvania in the field of neurotrauma, she is currently an Instructor in the Department of Neurosurgery and Penn Center for Brain Injury and Repair at the University of Pennsylvania, Philadelphia, PA, USA. Her research focuses on understanding potential mechanisms of chronic neurodegeneration after traumatic brain injury. William Stewart Dr William Stewart is Consultant and Lead Neuropathologist at the Southern General Hospital, Glasgow, and Honorary Clinical Associate Professor at the University of Glasgow, UK. He completed both his medical training and subsequent Ph.D. in neuroscience at the University of Glasgow before pursing postgraduate training in neuropathology. Glasgow has a long-established record in research in neurotrauma, with contributions to many of the key references in the field. Dr Stewart continues the Glasgow tradition in leading research in TBI, with particular emphasis on long-term outcomes after TBI. Page 7 of 7